This article seeks to review newer ART agents, as well as those in later stages of drug development, for the treatment of HIV-1 infection.
Jeremy D. Young, MD, MPH
Advertisement
Articles by Jeremy D. Young, MD, MPH
Advertisement
Latest Updated Articles
New and Pipeline Antiretroviral Agents for the Treatment of HIV-1 InfectionPublished: June 10th 2016 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
‘Complicating the Decision-Making’ for the Universal Birth Dose of the Hepatitis B Vaccine
2
FDA Plans to Review Already Approved RSV Immunizations
3
FDA Grants First Approval Under Priority Voucher Program, Fast-Tracking Antibiotic to Strengthen US Drug Supply Chain
4
NYU’s Vaccine Center: A Short History With Significant Contributions
5
